Clinical Trial Update: Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating allogeneic stem cell transplantation for systemic lupus erythematosus has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: Northwestern University | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: WITHDRAWN